Real estate for MFM physicians
MFM income supports aggressive real estate strategies. Here’s the playbook.
Author: Pouyan Golshani
Founder of GigHz. Physician, builder, and deep-tech advisor exploring the intersections of advanced materials, medicine, and market strategy. I help innovators refine ideas, connect to the right stakeholders, and bring meaningful solutions to life — one signal at a time.
Tax planning for MFM physicians: high W-2, high call burden
MFM income is high but on-call burden is heavy. Tax planning needs to reflect both.
PAD and CLI economics: where the procedural revenue actually flows
Peripheral arterial and critical limb ischemia procedures have unique economics. Here’s the rate data and operator considerations.
AI dictation and procedural tools for vascular surgery
Vascular AI is moving toward procedural dictation, coding, and case prep. Here’s the working stack.
Real estate for vascular surgeons
Vascular surgery income supports aggressive real estate. Here’s the playbook.
Tax planning for vascular surgeons with OBL equity
Vascular K-1 from endovascular OBL shields differently than W-2. Here’s the optimization stack.
Endovascular OBL ownership: the new ASC frontier for vascular surgeons
Endovascular labs are migrating outpatient — same procedural revenue, lower overhead, owner-equity. Here’s the modeling.
AI tools for urology
Urology AI is moving toward MRI fusion biopsy, robotics, and pathology. Here’s the directory.
Prostate cancer pathway economics
Urology owns the prostate cancer chain — biopsy, MRI, treatment selection. Here’s how to capture the economics.
Real estate for urologists
Urology income supports aggressive real estate. Here’s the playbook.